- Stocks
- Pharma & Healthcare
- KMS Medisurgi
KMS Medisurgi share price
NSE: KMSMEDIPharma & HealthcareMedical Instruments & Supplies
KMS Medisurgi at a glance
With a market capitalisation of ₹43 Cr, it ranks 3161st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Instruments & Supplies.
Its return on equity was 3.0% in FY26. Promoters held 74.42% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹43 CrRank 3161 on NSE
- Price to book
- 5.02×FY26
- ROE
- 3.0%FY26
- ROCE
- 4.8%FY26
- Debt to equity
- 0.09FY26
- Net profit margin
- 2.0%FY26
- Book value / share
- ₹25.20FY26
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
KMS Medisurgi financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating profit | — | — | — | — | — | — |
| Net profit | — | — | — | — | — | — |
| EPS (₹) | — | — | — | — | — | — |
| Total debt | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Shareholders' equity | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
KMS Medisurgi shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 74.42% | 74.42% | 74.42% | 74.42% | 74.42% | 74.42% |
| Non-institutions | 25.58% | 25.58% | 25.58% | 25.58% | 25.58% | 25.58% |
KMS Medisurgi vs peers
The listed Pharma & Healthcare companies nearest to KMS Medisurgi by market capitalisation.
Ask anything about KMS Medisurgi
Pivot answers on the live chart with evidence you can check, and tests strategies against KMSMEDI's own history. Try: “Why has KMSMEDI moved over the last three months?” · “Backtest a 50-day moving-average crossover on KMSMEDI over five years” · “Compare KMSMEDI with SHANMUGA on margins and valuation”
Frequently asked questions about KMS Medisurgi
What is the market cap of KMS Medisurgi?
KMS Medisurgi's market capitalisation is ₹43 Cr (₹43 Cr) at the 22 Oct 2026 close, ranking 3161st among the NSE companies Pivot tracks.
What is the ROE and ROCE of KMS Medisurgi?
Return on equity was 3.0% in FY26 and return on capital employed was 4.8% in FY26 (standalone figures).
Is KMS Medisurgi a debt-free company?
No. KMS Medisurgi's debt-to-equity ratio was 0.09 in FY26, with total debt of ₹1 Cr.
What is the shareholding pattern of KMS Medisurgi?
As of 30 Jun 2026: promoters 74.42%, non-institutions 25.58%.
Who are KMS Medisurgi's competitors?
The listed Pharma & Healthcare companies closest to KMS Medisurgi by market cap are Shanmuga Hospit, Mangalam Drugs And Organics, Amkay Products, Shelter Pharma, Vista Pharma and Sandu Pharma.
Is KMS Medisurgi a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out KMS Medisurgi's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KMSMEDI against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with K · all NSE stocks · this page as text